Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by pennyoilkingon May 02, 2019 6:33pm

62 Views

Post# 29703667

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Phase II ACT-NMIBC study

How do we know how many of the super embarrassing .30 .375 .50 or .54 have been exercised? No point for anymore PP’s unless over a dollar a share and only 10 million issued with a $1.50 warrant. Then again, the obvious way is to do a JV with MRNA now at $28.00!!! I own thousands of shares of Both stocks!

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features